THE DAY, IN CONTEXTPolaris InsightsAn AI-powered comprehensive news portal

POLARIS INSIGHTS

IRhythm plans Zio MCT FDA filing in 2027 while raising 2026 revenue outlook to $890M-$895M

This story focuses on IRhythm plans Zio MCT FDA filing in 2027 while raising 2026 revenue outlook to $890M-$895M.

Read the full account of the story

More from the Markets desk

More from Markets · Back to Polaris Insights